NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Public ClinicalTrials.gov record NCT06963034. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NBI-1117568 in Adults With Schizophrenia Who Warrant Inpatient Hospitalization
Study identification
- NCT ID
- NCT06963034
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Neurocrine Biosciences
- Industry
- Enrollment
- 284 participants
Conditions and interventions
Conditions
Interventions
- NBI-1117568 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 7, 2025
- Primary completion
- Sep 30, 2027
- Completion
- Sep 30, 2027
- Last update posted
- Mar 5, 2026
2025 – 2027
United States locations
- U.S. sites
- 21
- U.S. states
- 10
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Neurocrine Clinical Site | Bryant | Arkansas | 72022 | Recruiting |
| Neurocrine Clinical Site | Little Rock | Arkansas | 72211 | Recruiting |
| Neurocrine Clinical Site | Anaheim | California | 92805 | Recruiting |
| Neurocrine Clinical Site | Pico Rivera | California | 90660 | Recruiting |
| Neurocrine Clinical Site | San Diego | California | 92123 | Recruiting |
| Neurocrine Clinical Site | Sherman Oaks | California | 91403 | Recruiting |
| Neurocrine Clinical Site | Torrance | California | 90504 | Recruiting |
| Neurocrine Clinical Site | Hollywood | Florida | 33024 | Recruiting |
| Neurocrine Clinical Site | Miami Lakes | Florida | 33016 | Recruiting |
| Neurocrine Clinical Site | Atlanta | Georgia | 30331 | Recruiting |
| Neurocrine Clinical Site | Decatur | Georgia | 30030 | Recruiting |
| Neurocrine Clinical Site | Snellville | Georgia | 30078 | Recruiting |
| Neurocrine Clinical Site | Chicago | Illinois | 60640 | Recruiting |
| Neurocrine Clinical Site | Gaithersburg | Maryland | 20877 | Recruiting |
| Neurocrine Clinical Site | Watertown | Massachusetts | 02472 | Recruiting |
| Neurocrine Clinical Site | Marlton | New Jersey | 08053 | Recruiting |
| Neurocrine Clinical Site | Staten Island | New York | 10314 | Recruiting |
| Neurocrine Clinical Site | The Bronx | New York | 10461 | Recruiting |
| Neurocrine Clinical Site | Austin | Texas | 78754 | Recruiting |
| Neurocrine Clinical Site | DeSoto | Texas | 75115 | Recruiting |
| Neurocrine Clinical Site | Houston | Texas | 77043 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06963034, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 5, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06963034 live on ClinicalTrials.gov.